This course is developed by Medscape Education Global. Medscape is one of the leading digital platforms for medical education. A comprehensive array of innovative formats, in multiple languages, insures the right educational solution is available to best achieve desired objectives—from text-based articles to state-of-the-art multimedia formats and the most sophisticated simulation environments. Activity formats include Clinical Insights, Expert Perspective, Instructional Series Programming, Next-Generation Symposia, Patient-Case Approaches, including Simulation and Clinical Advances.
In this lively inter-disciplinary dialogue between a leading diabetologist and an internationally renowned cardiologist, Dr Naveed Sattar from Glasgow, UK, and Dr Kausik Ray, London, UK, debate the state-of-the art for best diabetes care with a particular focus on latest results from major cardiovascular outomes trials with GLP-1 receptor agonists and SGLT2 inhibitors and how these have shaped the most recent ESC/EASD and EASD/ADA guidelines for the management of patients with type 2 diabetes, especially those at high cardiovascular risk or established CV disease. They further explore the mode-of-action of these novel glucose-lowering drugs with CV benefits and rules for their safe use in clinical practice, and present some typical case studies from cardiology clinic..
Made for: Diabetologists, Endocrinologists, Cardiologists, Primary Care Physicians
Disease areas: Diabetes
Developed by: Medscape